Why the study?
Coronary obstruction and access are concerns in patients undergoing redo TAVI.
Does the implant depth of a SAPIEN 3 Ultra within an ACURATE neo2 affect neoskirt height, leaflet overhang, and hydrodynamic performance in an in vitro model?
Does the implant depth of a SAPIEN 3 Ultra within an ACURATE neo2 affect neoskirt height, leaflet overhang, and hydrodynamic performance in an in vitro model?
In an in vitro model of redo TAVI, deploying a SAPIEN 3 Ultra within an ACURATE neo2 yields favorable hydrodynamics and a neoskirt design that may facilitate coronary access.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Akodad et al. (2023) studied Redo transcatheter aortic valve implantation (TAVI). SAPIEN 3 Ultra (S3U) within ACURATE neo2 (ACn2) THV vs. Low vs high implant depth was evaluated on Neoskirt height, leaflet overhang, leaflet deflection, THV expansion and performance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: